Document is current

Documents that mention this clinical trial

Extending the time window for intravenous tenecteplase in patients with distal medium vessel occlusions stroke: study protocol and rationale
https://doi.org/10.1136/svn-2025-004727

Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications
https://doi.org/10.1136/heartjnl-2024-325249

Documents that mention this clinical trial

Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research
https://doi.org/10.1136/svn-2021-001134

Extending the time window for intravenous tenecteplase in patients with distal medium vessel occlusions stroke: study protocol and rationale
https://doi.org/10.1136/svn-2025-004727

Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial
https://doi.org/10.1136/svn-2023-002820

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial
https://doi.org/10.1136/svn-2023-002310

Evaluating the concordance between International Classification of Diseases, Tenth Revision Code and stroke severity as measured by the National Institutes of Health Stroke Scale
https://doi.org/10.1136/bmjno-2024-000831

European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion
https://doi.org/10.1136/neurintsurg-2021-018589

Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials
https://doi.org/10.1136/svn-2023-002396

Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases
https://doi.org/10.1136/svn-2020-000533

Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial
https://doi.org/10.1136/bmj-2025-085810

Tenecteplase versus standard care in patients with acute basilar artery occlusion: a multi-centre, prospective, randomised, open-label, blinded endpoint, phase 3, controlled trial
https://doi.org/10.1136/svn-2025-004432

Documents that mention this clinical trial

Extending the time window for intravenous tenecteplase in patients with distal medium vessel occlusions stroke: study protocol and rationale
https://doi.org/10.1136/svn-2025-004727

Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications
https://doi.org/10.1136/heartjnl-2024-325249

Documents that mention this clinical trial

Extending the time window for intravenous tenecteplase in patients with distal medium vessel occlusions stroke: study protocol and rationale
https://doi.org/10.1136/svn-2025-004727

Chinese stroke association guidelines on reperfusion therapy for acute ischaemic stroke 2024
https://doi.org/10.1136/svn-2024-003977

Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications
https://doi.org/10.1136/heartjnl-2024-325249

Documents that mention this clinical trial

Extending the time window for intravenous tenecteplase in patients with distal medium vessel occlusions stroke: study protocol and rationale
https://doi.org/10.1136/svn-2025-004727

Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications
https://doi.org/10.1136/heartjnl-2024-325249